Some of the players in canine oral chewable tablets market are Zoetis, Inc. (Pfizer) (U.S), Virbac AH Inc. (France), Elanco (Eli Lilly and Co.) (U.S.), Boehringer Ingelheim vetmedica, Inc. (Boehringer Ingelheim) (Germany), Pala-Tech Laboratories (U.S.), Bayer HealthCare LLC, (Bayer AG) (Germany), Merck Animal Health (Merck &co. Inc.) (U.S.), and Putney, Inc. (Dechra Pharmaceuticals) (U.K.) to name a few.